DOI:
江苏卫生事业管理:2018,Vol.>>Issue(9):1033-1037
本文二维码信息
码上扫一扫!
DRG对原发性支气管肺癌临床路径实施效果的优化研究△
邱晶青,汤天凤,薛缪群,孙蓉蓉,韩光曙
(清华大学医院管理研究院;南京大学医学院附属鼓楼医院)
Research on Optimization of Clinical Pathway Effect of DRG:Based on Primary Bronchial Lung Cancer△
Qiu Jingqing,Tang Tianfeng,Xue Miaoqun,Sun Rongrong,Han Guangshu
(Institute for Hospital Management of Tsinghua University;The Affiliated Drum Tower Hospital of Nanjing University Medical School)
摘要
图/表
参考文献
相似文献
本文已被:浏览 2390次   下载 2
    
中文摘要: 目的:分析某三甲医院原发性支气管肺癌临床路径的实施效果,探索临床路径优化策略。方法:选择2016年收治的572例原发性支气管肺癌患者,其中314例为临床路径入径组,其余258例为未入径组,比较优化前后入径组和未入径组的性别、年龄、平均住院日、住院费用等。结果:按DRG分组细化临床路径管理后,住院费用管理较分组前有了较大的提升。结论:本次优化策略证明有效。
Abstract:Objective:To analyze the implementation of the clinical pathway of primary bronchial lung cancer in a Tertiary Level A hospital and to explore the optimization strategies. Method:314 out of 572 patients with primary bronchial lung cancer who were admitted via clinical pathways were classified as intake group,and 258 were classified non-intake group. The gender,age,average length of stay,cost were compared before and after optimization between intake group and non-intake group. Results:After refining the clinical pathway using DRG,the management of cost was greatly improved. Conclusion:The optimization strategies proved effective.
文章编号:     中图分类号:    文献标志码:
基金项目:南京医学科技发展重点项目(ZKX160047);南京大学医院管理研究所基金(NDYG2016009) 南京医学科技发展重点项目(ZKX160047);南京大学医院管理研究所基金(NDYG2016009)
引用文本:
邱晶青,汤天凤,薛缪群,孙蓉蓉,韩光曙.DRG对原发性支气管肺癌临床路径实施效果的优化研究△[J].江苏卫生事业管理,2018,29(9):1033-1037.
Qiu Jingqing,Tang Tianfeng,Xue Miaoqun,Sun Rongrong,Han Guangshu.Research on Optimization of Clinical Pathway Effect of DRG:Based on Primary Bronchial Lung Cancer△[J].Jiangsu Health System Management,2018,29(9):1033-1037.

用微信扫一扫

用微信扫一扫